MedPath

SUMMER-study

Conditions
Infertility, subfertility, male infertility, nutritional supplements
Registration Number
NL-OMON26205
Lead Sponsor
Radboud University Medical CentreDepartment of Obstetrics and GynaecologyPO Box 9101 6500HB NijmegenThe Netherlands
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
1200
Inclusion Criteria

Couples with failure to conceive for at least 12 months

Couples starting with EM or 1st/ 2nd/3rd cycle of IUI (with/without ovarian stimulation) or IVF/ICSI

Exclusion Criteria

Planned or performed diagnostic testicular biopsy (TESE) or percutaneous epididymal sperm aspiration (PESA)

Ovulation induction (OI) without IUI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To test the hypothesis that the number of ongoing pregnancies (i.e. ≥12 weeks of gestation) will be improved by 7.5% in couples treated with Impryl® for infertility (IUI, IVF/ICSI or EM setting).
Secondary Outcome Measures
NameTimeMethod
Overall pregnancy rate. Time to pregnancy defined as both the time between a) start of intervention and reaching ongoing pregnancy, and as b) start of fertility treatment and reaching ongoing pregnancy. Change in semen parameters between baseline and 3 months intervention, based on pre-wash total motile sperm count (TMSC) from the subpopulation from Radboudumc and sites that deliver a pre-wash TMSC before IUI/IVF/ICSI. Number of miscarriages defined as a non-vital intra-uterine pregnancy before 16 weeks of gestation. Number of ongoing pregnancies above ≥ 20 weeks. Live birth rate defined as beyond 24 weeks of gestation, the birth of a living child. Live births will be reported within follow-up time of 15 months. Furthermore the following adverse events will be reported: gastro-intestinal problems such as reflux, obstipation, diarrhea, nausea or vomiting, furthermore loss of appetite, headache, dizziness, pruritus or skin rash.
© Copyright 2025. All Rights Reserved by MedPath